Pharmaceutical agent for treatment and/or prevention of cancer

Details for Australian Patent Application No. 2011211700 (hide)

Owner Toray Industries, Inc.

Inventors Ido, Takayoshi; Okano, Fumiyoshi; Narita, Yoshinori

Agent Pizzeys

Pub. Number AU-A-2011211700

PCT Pub. Number WO2011/096535

Priority 2010-023455 04.02.10 JP

Filing date 4 February 2011

Wipo publication date 11 August 2011

International Classifications

C07K 16/30 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 31/337 - having four-membered rings, e.g. taxol

A61K 31/475 - having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

A61K 31/675 - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 Antineoplastic agents

A61P 35/02 Antineoplastic agents

A61P 43/00 Drugs for specific purposes, not provided for in groups

Event Publications

23 August 2012 PCT application entered the National Phase

  PCT publication WO2011/096535 Priority application(s): WO2011/096535

30 August 2012 Amendment Made

  The nature of the amendment is: Amend the invention title to read Medicament for treating and/or preventing cancer

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011211739-Method for separating arsenic mineral from copper material with high arsenic content

2011211699-Pharmaceutical composition for treatment and/or prevention of cancer